Latest Kaiser Health News Stories
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates’ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California’s first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.
Unlike in the U.S., health insurance in Germany doesn’t cover birth control. German health advocates say that causes health problems — but change is unlikely.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand “wellness” programs aimed at getting people with insurance to practice better health habits – even though research has shown the efforts don’t generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book “The Price We Pay” about why health care costs so much.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.